<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.advancesinsmallanimal.com/?rss=yes"><title>Advances in Small Animal Medicine &amp; Surgery</title><description>Advances in Small Animal Medicine &amp; Surgery RSS feed: Current Issue. Each month,  
 Advances in Small Animal Medicine and Surgery 
  features abstracts of material from recent publications and 
presentations, followed by comments from specialists in the field. Small animal veterinarians and veterinary technicians gain new insight 
into specific topics and increase their skills in judging how to apply new tests and treatments in practice situations.</description><link>http://www.advancesinsmallanimal.com/?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2010 Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>Advances in Small Animal Medicine &amp; Surgery</prism:publicationName><prism:issn>1041-7826</prism:issn><prism:volume>23</prism:volume><prism:number>2</prism:number><prism:publicationDate>February 2010</prism:publicationDate><prism:copyright> © 2010 Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.advancesinsmallanimal.com/article/PIIS1041782610000022/abstract?rss=yes"/><rdf:li rdf:resource="http://www.advancesinsmallanimal.com/article/PIIS1041782610000034/abstract?rss=yes"/><rdf:li rdf:resource="http://www.advancesinsmallanimal.com/article/PIIS1041782610000046/abstract?rss=yes"/><rdf:li rdf:resource="http://www.advancesinsmallanimal.com/article/PIIS1041782610000058/abstract?rss=yes"/><rdf:li rdf:resource="http://www.advancesinsmallanimal.com/article/PIIS104178261000006X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.advancesinsmallanimal.com/article/PIIS1041782610000071/abstract?rss=yes"/><rdf:li rdf:resource="http://www.advancesinsmallanimal.com/article/PIIS1041782610000083/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.advancesinsmallanimal.com/article/PIIS1041782610000022/abstract?rss=yes"><title>Confronting the Controversy Over Behavior Modification Methodologies</title><link>http://www.advancesinsmallanimal.com/article/PIIS1041782610000022/abstract?rss=yes</link><description>Behavioral complaints are pervasive among pet owners. While the severity of the grievance varies, almost every care giver can find some aspect of their pet's behavior that they would like to improve. Unarguably, the most problematic and dangerous behavioral issues involve aggression, particularly aggression directed toward people.</description><dc:title>Confronting the Controversy Over Behavior Modification Methodologies</dc:title><dc:creator>LORE I. HAUG</dc:creator><dc:identifier></dc:identifier><dc:source>Advances in Small Animal Medicine &amp; Surgery 23, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>Advances in Small Animal Medicine &amp; Surgery</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1041-7826(10)X0002-0</prism:issueIdentifier><prism:section>Guest Editorial</prism:section><prism:startingPage>1</prism:startingPage><prism:endingPage>3</prism:endingPage></item><item rdf:about="http://www.advancesinsmallanimal.com/article/PIIS1041782610000034/abstract?rss=yes"><title>Human immunoglobulin treatment for immune-mediated thrombocytopenia in dogs</title><link>http://www.advancesinsmallanimal.com/article/PIIS1041782610000034/abstract?rss=yes</link><description>Immune-mediated thrombocytopenia (IMT) in dogs is a blood disorder in which antibodies bound to the surface of platelets cause platelet destruction and removal by the mononuclear phagocytic system leading to thrombocytopenia. The binding antibodies can be antiplatelet autoantibodies, immune complexes bound to the platelet membrane, antibodies bound to platelet antigens altered during the course of disease, or antibodies bound to foreign antigens absorbed to the platelet surface. IMT may be a primary condition or secondary to known antigenic stimuli, such as neoplasia, infectious diseases, and drugs. Methods for the detection of platelet-bound antibody include ELISA, flow cytometry, and immunoradiometric methods.</description><dc:title>Human immunoglobulin treatment for immune-mediated thrombocytopenia in dogs</dc:title><dc:creator></dc:creator><dc:identifier></dc:identifier><dc:source>Advances in Small Animal Medicine &amp; Surgery 23, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>Advances in Small Animal Medicine &amp; Surgery</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1041-7826(10)X0002-0</prism:issueIdentifier><prism:section>Critical Care</prism:section><prism:startingPage>3</prism:startingPage><prism:endingPage>4</prism:endingPage></item><item rdf:about="http://www.advancesinsmallanimal.com/article/PIIS1041782610000046/abstract?rss=yes"><title>Adverse reactions to milbemycin treatment for demodicosis</title><link>http://www.advancesinsmallanimal.com/article/PIIS1041782610000046/abstract?rss=yes</link><description>Generalized demodicosis can be difficult to treat successfully. Amitraz, a monoamine oxidase inhibitor and α2 adrenergic agonist, is administered topically as a rinse to treat demodicosis. The efficacy of amitraz for canine demodicosis varies from 0 to 100%, with adult-onset demodicosis typically having a poor response. Adverse effects can include neurological signs (depression and ataxia), vomiting, diarrhea, hyperglycemia, polyphagia, and polydipsia. Because of its topical administration, human exposure and potential toxicity are a concern.</description><dc:title>Adverse reactions to milbemycin treatment for demodicosis</dc:title><dc:creator></dc:creator><dc:identifier></dc:identifier><dc:source>Advances in Small Animal Medicine &amp; Surgery 23, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>Advances in Small Animal Medicine &amp; Surgery</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1041-7826(10)X0002-0</prism:issueIdentifier><prism:section>Dermatology</prism:section><prism:startingPage>4</prism:startingPage><prism:endingPage>5</prism:endingPage></item><item rdf:about="http://www.advancesinsmallanimal.com/article/PIIS1041782610000058/abstract?rss=yes"><title>Radioiodine treatment of feline thyroid carcinoma</title><link>http://www.advancesinsmallanimal.com/article/PIIS1041782610000058/abstract?rss=yes</link><description>Thyroid carcinoma is responsible for 1 to 3% of the hyperthyroidism cases in cats. Reported features of thyroid carcinoma on scintigraphy and histopathology have been variable. Scintigraphic characteristics that are consistent with thyroid malignancy include multiple areas of hyperfunctional tissue and intrathoracic lesions. However, ectopic thyroid tissue can be responsible for the same scintigraphic findings. Distinguishing thyroid adenoma from carcinoma is also critical, as successful management of the thyroid carcinoma requires a different treatment strategy.</description><dc:title>Radioiodine treatment of feline thyroid carcinoma</dc:title><dc:creator></dc:creator><dc:identifier></dc:identifier><dc:source>Advances in Small Animal Medicine &amp; Surgery 23, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>Advances in Small Animal Medicine &amp; Surgery</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1041-7826(10)X0002-0</prism:issueIdentifier><prism:section>Endocrinology</prism:section><prism:startingPage>5</prism:startingPage><prism:endingPage>6</prism:endingPage></item><item rdf:about="http://www.advancesinsmallanimal.com/article/PIIS104178261000006X/abstract?rss=yes"><title>Metronomic therapy for incompletely resected soft tissue sarcomas</title><link>http://www.advancesinsmallanimal.com/article/PIIS104178261000006X/abstract?rss=yes</link><description>The ability to stimulate angiogenesis is essential for malignant tumors to grow progressively and metastasize. Metronomic therapy is continuous administration of fixed, low doses of chemotherapy drugs without prolonged breaks. This therapy has been shown to be an effective means of inhibiting tumor angiogenesis in mice.</description><dc:title>Metronomic therapy for incompletely resected soft tissue sarcomas</dc:title><dc:creator></dc:creator><dc:identifier></dc:identifier><dc:source>Advances in Small Animal Medicine &amp; Surgery 23, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>Advances in Small Animal Medicine &amp; Surgery</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1041-7826(10)X0002-0</prism:issueIdentifier><prism:section>Oncology</prism:section><prism:startingPage>6</prism:startingPage><prism:endingPage>6</prism:endingPage></item><item rdf:about="http://www.advancesinsmallanimal.com/article/PIIS1041782610000071/abstract?rss=yes"><title>Hyperadrenocorticism and preputial cytology in male ferrets</title><link>http://www.advancesinsmallanimal.com/article/PIIS1041782610000071/abstract?rss=yes</link><description>Up to 25% of ferrets (Mustela putorius furo) in the United States may be at risk for adrenocortical disease. It is believed that early age gonadectomy of ferrets results in an increase in stimulation of the adrenal glands by luteinizing hormone because of a lack of negative feedback from hormones that would have been released by the gonads. Constant stimulation of the adrenal glands by luteinizing hormone results in adrenocortical hyperplasia or development of adrenal neoplasia. Most commercially raised ferrets in the U.S. undergo gonadectomy at approximately 6 weeks of age.</description><dc:title>Hyperadrenocorticism and preputial cytology in male ferrets</dc:title><dc:creator></dc:creator><dc:identifier></dc:identifier><dc:source>Advances in Small Animal Medicine &amp; Surgery 23, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>Advances in Small Animal Medicine &amp; Surgery</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1041-7826(10)X0002-0</prism:issueIdentifier><prism:section>Small Mammals</prism:section><prism:startingPage>7</prism:startingPage><prism:endingPage>8</prism:endingPage></item><item rdf:about="http://www.advancesinsmallanimal.com/article/PIIS1041782610000083/abstract?rss=yes"><title>Adhesive incise drapes and prevention of bacterial contamination</title><link>http://www.advancesinsmallanimal.com/article/PIIS1041782610000083/abstract?rss=yes</link><description>All surgical incisions carry the risk of infection. Infection rates for clean surgical procedures in dogs are 2.5 to 4.8%. Rates for clean contaminated, contaminated, and dirty procedures are higher. Most incision infections are caused by skin commensal bacteria that contaminate the surgical wound. Preoperative preparation of the surgical site removes most skin surface bacteria. However, some bacteria will remain and continue to multiply during the procedure. Also, bacteria sequestered in hair follicles may rise to the skin surface during surgery. Longer surgical procedures are at higher risk for wound infection because of the increased opportunity for bacterial recolonization of the skin, as well as greater handling of the skin at the surgical site and use of implants.</description><dc:title>Adhesive incise drapes and prevention of bacterial contamination</dc:title><dc:creator></dc:creator><dc:identifier></dc:identifier><dc:source>Advances in Small Animal Medicine &amp; Surgery 23, 2 (2010)</dc:source><dc:date>2010-02-01</dc:date><prism:publicationName>Advances in Small Animal Medicine &amp; Surgery</prism:publicationName><prism:publicationDate>2010-02-01</prism:publicationDate><prism:volume>23</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S1041-7826(10)X0002-0</prism:issueIdentifier><prism:section>Surgery (Soft Tissue)</prism:section><prism:startingPage>8</prism:startingPage><prism:endingPage>8</prism:endingPage></item></rdf:RDF>